Classys approaches 50,000 global device sales as expanded product lineup drives 29% YoY export growth in first half 2026
Executive summary: Classys announced it is close to selling 50,000 devices globally after adding MNRF, laser and dermabrasion products to its HIFU and MRF lineup, with first‑half 2026 exports up 29% YoY (excluding Brazil). The sales milestone and export growth signal successful diversification beyond its original HIFU core, expanding the company’s addressable market and reinforcing its growth trajectory.
Who is involved: Classys (medical‑aesthetics device manufacturer), its global customers and distributors, and the Brazilian subsidiary whose shipments were excluded from the export figure.
Likely next: Classys will continue to roll out the new laser and dermabrasion devices in key markets and report full‑year 2026 financial results in early 2027.
Classys reported nearing 50,000 devices sold worldwide after expanding its portfolio beyond high-intensity focused ultrasound (HIFU) and multi‑polar radiofrequency (MRF) to include microneedle radiofrequency (MNRF), laser and dermabrasion systems. Export sales, excluding shipments to its Brazilian subsidiary, rose 29% year‑over‑year in the first half of 2026, indicating broader demand for its expanded line‑up. The milestone underscores the company’s shift from a niche HIFU focus to a diversified medical‑aesthetics provider, strengthening its medium‑ to long‑term growth foundation.
Timeline
- — Classys Nears 50,000 Devices Sold Globally as Full-Lineup Growth Accelerates (PR Newswire)
Analysis — what this means
Sectors affected
- medical aesthetics device manufacturing
- high‑intensity focused ultrasound (HIFU)
- multi‑polar radiofrequency (MRF)
- microneedle radiofrequency (MNRF)
Sources
Related cases
- Europe’s wind power capacity surged 30% YoY to 8.8 GW in H1 2026, signaling accelerating renewable investment and potential pressure on fossil fuel markets
- Keymed Biosciences posts strong H1 2026 growth, with core product Kangyueda sales up 132% YoY, underscoring momentum in China's biotech sector
- Microcredit boom is squeezing family budgets, with 3.8 million loans up 46% YoY despite experts warning it fails to ease debt
- Europe’s 50 most active equity investors in H1 2026 reveals shifting VC concentration toward AI and climate tech amid broader European fundraising slowdown
- Flávio Bolsonaro’s presidential bid is losing traction among key Brazilian constituencies, bolstering incumbent Lula’s position
- Utenos Trikotažas keeps export‑market growth and double‑digit brand gains despite an 8.1% YoY revenue dip in H1 2026